Hybrid Face Lift in Brasília — non-surgical signature protocol

The Hybrid Face Lift is a structured multi-modal protocol that addresses facial ageing across all four anatomical layers simultaneously — skin quality, subcutaneous volume, ligamentous support, and bony architecture — without requiring surgical access. No single injectable or device achieves this range; the protocol's effectiveness derives from the deliberate sequencing of complementary mechanisms.

Facial ageing is not a single-variable problem. Systematic imaging studies — including the work of Lambros (Plastic and Reconstructive Surgery, 2007) and subsequent volumetric CT analyses — demonstrated that the face loses fat compartments asymmetrically, bony resorption accelerates after the fifth decade, and skin loses structural collagen at roughly 1% per year from the age of 25 (Varani et al., J Invest Dermatol, 2006). A treatment that only tightens surface skin without restoring volume produces the characteristic "pulled" appearance of older surgical approaches. A treatment that only adds volume without improving skin quality leaves texture and luminosity unaddressed.

The Hybrid Face Lift integrates three functional tiers. The first tier — autologous fat grafting in micro-fat and nano-fat fractions — restores volumetric scaffolding in the deep and superficial fat compartments while delivering regenerative stromal-vascular fraction cells to the dermis (Tonnard et al., Aesthet Surg J, 2013). The second tier — poly-L-lactic acid (Sculptra) or calcium hydroxylapatite (Radiesse, HarmonyCa) — induces sustained collagen neogenesis in the reticular dermis over 3–6 months, prolonging and amplifying the volumetric result. The third tier — radiofrequency microneedling (Morpheus8) or fractional CO₂/Er:YAG laser (Fotona) — remodels the extracellular matrix, improves surface texture, and tightens the superficial musculo-aponeurotic system (SMAS) region from below the dermis.

Sequencing matters. Fat grafting is performed first, as subsequent energy delivery can accelerate graft resorption if applied too early. Biostimulators are introduced at 4–6 weeks post-grafting. Energy-based devices follow at 6–8 weeks, once initial graft integration is confirmed. The interval is not arbitrary — it mirrors the fibroblast activation windows described in the regenerative aesthetics literature.

Because the protocol is delivered in phases, there is no single recovery arc. Each component carries its own post-procedure window.

Fat grafting (where included) produces the most significant early post-procedure changes: swelling and bruising over 7–14 days, with final graft take assessed at 3 months. Patients are advised to avoid significant pressure on the treated areas and to protect from direct sun exposure during this period. Social downtime is generally 7–10 days for the fat-grafting session.

Biostimulator sessions produce mild localised swelling and occasional bruising for 3–5 days. Massage is contraindicated for the first 24 hours but may be recommended thereafter depending on the product used. The visible result builds over 6–12 weeks as collagen deposition progresses.

Energy-based device sessions (radiofrequency microneedling or fractional laser) produce erythema and superficial micro-crusting for 3–7 days. Sun protection factor 50+ is mandatory for a minimum of 4 weeks post-treatment. The skin-quality improvement continues for up to 6 months as dermal remodelling completes.

Comparison with surgical face lift: a surgical rhytidectomy addresses skin and SMAS in a single operative session with more immediate and dramatic correction of ptosis. Its primary limitations are general or deep sedation anaesthesia, 2–4 weeks of visible recovery, and the specific risks of haematoma, nerve paresis, and scarring. The Hybrid Face Lift does not replicate the tightening capacity of surgical undermining and SMAS plication for advanced ptosis. What it offers is multi-layer biological regeneration — fat, collagen, and dermal matrix — with a recovery profile distributed across shorter individual sessions rather than concentrated into one surgical episode. For the correct candidate, the functional and aesthetic result is clinically meaningful and not recognisable as a procedure. For a patient with significant excess skin or severe ptosis, surgery remains the more appropriate primary intervention.

Most patients undergoing the full protocol describe the result at 6 months as a version of themselves that appears rested and structurally coherent — the most consistent feedback is that colleagues and acquaintances comment on their appearance without identifying a specific change.

Updated 13 May 2026